InduPro Raises $77M, Begins First Human Trial of Cancer Drug

InduPro, a biotech startup with operations in Seattle and Cambridge, Mass., raised $77M in Series B funding as it begins a Phase 1 clinical trial of its lead cancer drug candidate, IDP-001. The experimental antibody-drug conjugate is designed to target cancer cells through two proteins on their surface.